CAM acts for Glenmark Pharma on sale of VWash hygiene products to HUL (Mar 20)

Leading FMCG player Hindustan Unilever (HUL) on Friday said it has completed the acquisition of VWash from pharma major Glenmark Pharmaceuticals. The company, however, did not disclose the value of the transaction.

The Economic Times

Cyril Amarchand Mangaldas advised Glenmark Pharmaceuticals Limited led by a team of partner Manisha Kumar, senior associate Aviral Chauhan, and associate Shaleen Tiwari.

2020-03-23

Deal value: Confidential

{incomplete}

Comments

Pharma Co 2 Jul 2020, 16:56
+6 -0
Wow. Three big pharma deals. Wockhardt, Piramal and this. Looks like their pharma practice is doing very well. Health is a good space to be right now but requires a lot of tech expertise.
Observer 3 Jul 2020, 09:16
+2 -0
Yes, one of the few firms that is heavily invested in pharma. They have a solid knowledge base.